| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_75176bf90651e51270734d5b96c27929
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a7f6dde29198669409f27a4e075ae661
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d324ea5f00999855eb6d821404e5e20f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f95647eb1676cf0ebbc50621c2de3090
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c7fe8a0750185906124e3420c51e2a7e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b1493f3cbdae6efa0f6b1e90736f7f8e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d97b0c210652af3300fed2b976dafd58 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F5-025
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F5-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D257-04 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F5-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D257-04 |
| filingDate |
2005-12-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_481b62705379dd79ab3e3f1eb626d08d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f74c7a8ad22a4b5fb839814a9e2cab5f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_38694519fefb308573277d2505ad2946
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_054f64877fd5541ff83b85ccaef71e91
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0f67a0bcd6062a8c83bf372078025075
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cf4f4c9b0e5afae64af7cad8272c827b |
| publicationDate |
2006-06-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2006067216-A2 |
| titleOfInvention |
Intermediate compounds for the preparation of an angiotensin ii receptor and process for the preparation of valsartan |
| abstract |
It comprises new substituted 4-valinylmethylphenyl boronic acids of formula (II) and their derivatives and also its preparation process. It also comprises a preparation process of Valsartan (I) from such intermediates. The process comprises the reaction of the new 4-valinylmethylphenyl boronic compounds with a (halophenyl)tetrazole compound which proceeds with high yields. The process is particularly advantageous in its practical industrial realization because it avoids the use of azide derivatives and also the use of expensive biphenyl intermediates. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2010081904-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007071750-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-100522953-C
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8492577-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2009125416-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2246329-A1 |
| priorityDate |
2004-12-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |